KMS Medisurgi board approves unaudited standalone financial results for the half-year ended September 30
BSE India
KMS Medisurgi board approves the unaudited standalone financial results, Statement of Assets and Liabilities, and Statement of Cash Flows for the half-year ended September 30, 2026. The company also takes on record the Limited Review Report provided by the independent auditors. The announcement serves as a procedural filing of financial results without specific numerical performance metrics.